The Women’s plays host to major research on antibiotic resistance

Researcher in lab
The Research Hub will look closely at resistance in sexually transmitted diseases
5 September 2019 | Research and clinical trials

A recently announced $10m Research Hub tackling antimicrobial resistance in sexually transmitted diseases is collaborating with the Royal Women’s Hospital to do part of the research.

Dr Gerald Murray from the Centre for Women’s Infectious Diseases at the Women’s is a partner investigator for the ARC Research Hub to Combat Antimicrobial Resistance, led by Prof Rebecca Guy, and will be contributing to the research with over 20 organisations across Australia.

Dr Murray congratulated the Kirby Institute at the UNSW Sydney for securing the funding from The Australian Research Council.

“This is a critical time to tackle antibiotic resistance, which poses a substantial and increasing threat to public health,” Dr Murray said. “A major area of concern relating to this is sexually transmitted bacterial infections.”

This Hub will bring together Australian and global expertise and industry innovation in diagnostics and pharmaceuticals under the umbrella of antimicrobial stewardship and for the first time, create an enhanced multi-disciplinary pre-commercialisation environment.

“The work conducted at the Royal Women’s Hospital will support the efficient development of new low-cost diagnostic tools and protocols to identify new antibiotic compounds, and will capitalise on established expertise in sexually transmitted infections,” added Dr Murray.  

The ARC Research Hub to Combat Antimicrobial Resistance is a collaboration between the following organisations:

Australian universities: UNSW Sydney (Kirby Institute, Centre for Social Research in Health), University of Queensland, Monash University, UTS and University of Melbourne.

Industry and partner organisations: SpeeDx Pty Ltd, Cepheid, Recce Pharmaceuticals Ltd, Opal Biosciences Ltd, Boulos and Cooper Pharmaceuticals Pty Ltd, The Global Antibiotic Research & Development Partnership (GARDP), The Foundation for Innovative New Diagnostics (FIND), the Central and Eastern Sydney PHN, and NPS MedicineWise.

Other collaborating organisations: Murdoch Children's Research Institute, WHO Collaborating Centre for Sexually Transmitted Infections and Antimicrobial Resistance, Melbourne Sexual Health Clinic, Western Sydney Sexual Health Centre, Sydney Sexual Health Centre, Papua New Guinea Institute of Medical Research, and Thai Red Cross AIDS Research Centre.

Share this page